Company
Now Is The Time To Build A Position In Spyre Therapeutics Inc (NASDAQ:SYRE)
Spyre Therapeutics Inc (NASDAQ:SYRE)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting 2.82. At the close of